Home NDC 67046-664 SEROQUEL
Product NDC 67046-664
11-digit product format 670460664
Labeler code 67046
Product ID 67046-664_276e53bf-d3c0-4457-a76e-ee39c1cd2a3d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Quetiapine fumarate
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Contract Pharmacy Services-PA
Application NDA020639
Marketing category NDA
Marketing start 2010-06-01
Marketing end 0000-00-00
Substance QUETIAPINE FUMARATE
Active strength 300 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 67046-664-30 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 67046-664-30 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 67046-664-30 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 67046-664-30 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 67046-664-30 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 67046-664-30 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 67046-664-30 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 67046-664-30 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 67046-664-30 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 67046-664-30 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 67046-664-30 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 67046-664-30 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 67046-664-30 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 67046-664-30 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 67046-664-30 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 67046-664-30 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 67046-664-30 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 67046-664-30 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 67046-664-30 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 67046-664-30 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 67046-664-30 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 67046-664-30 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020639-001 SEROQUEL QUETIAPINE FUMARATE EQ 25MG BASE TABLET / ORAL AB RLD, RS 1997-09-26 N020639-002 SEROQUEL QUETIAPINE FUMARATE EQ 100MG BASE TABLET / ORAL AB RLD 1997-09-26 N020639-003 SEROQUEL QUETIAPINE FUMARATE EQ 200MG BASE TABLET / ORAL AB RLD 1997-09-26 N020639-004 SEROQUEL QUETIAPINE FUMARATE EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-12-20 N020639-005 SEROQUEL QUETIAPINE FUMARATE EQ 300MG BASE TABLET / ORAL AB RLD, RS 2000-07-26 N020639-006 SEROQUEL QUETIAPINE FUMARATE EQ 400MG BASE TABLET / ORAL AB RLD 2005-10-04 N020639-007 SEROQUEL QUETIAPINE FUMARATE EQ 50MG BASE TABLET / ORAL AB RLD 2005-10-04
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 8 · 287 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020639-001 SEROQUEL EQ 25MG BASE TABLET / ORAL AB RLD, RS 1997-09-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020639-002 SEROQUEL EQ 100MG BASE TABLET / ORAL AB RLD 1997-09-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020639-003 SEROQUEL EQ 200MG BASE TABLET / ORAL AB RLD 1997-09-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020639-004 SEROQUEL EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-12-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020639-005 SEROQUEL EQ 300MG BASE TABLET / ORAL AB RLD, RS 2000-07-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020639-006 SEROQUEL EQ 400MG BASE TABLET / ORAL AB RLD 2005-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020639-007 SEROQUEL EQ 50MG BASE TABLET / ORAL AB RLD 2005-10-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020639-001 SEROQUEL EQ 25MG BASE TABLET / ORAL AB RLD, RS 1997-09-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020639-002 SEROQUEL EQ 100MG BASE TABLET / ORAL AB RLD 1997-09-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020639-003 SEROQUEL EQ 200MG BASE TABLET / ORAL AB RLD 1997-09-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020639-004 SEROQUEL EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-12-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020639-005 SEROQUEL EQ 300MG BASE TABLET / ORAL AB RLD, RS 2000-07-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020639-006 SEROQUEL EQ 400MG BASE TABLET / ORAL AB RLD 2005-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020639-007 SEROQUEL EQ 50MG BASE TABLET / ORAL AB RLD 2005-10-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020639-001 SEROQUEL EQ 25MG BASE TABLET / ORAL AB RLD, RS 1997-09-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020639-002 SEROQUEL EQ 100MG BASE TABLET / ORAL AB RLD 1997-09-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020639-003 SEROQUEL EQ 200MG BASE TABLET / ORAL AB RLD 1997-09-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020639-004 SEROQUEL EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-12-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020639-005 SEROQUEL EQ 300MG BASE TABLET / ORAL AB RLD, RS 2000-07-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020639-006 SEROQUEL EQ 400MG BASE TABLET / ORAL AB RLD 2005-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020639-007 SEROQUEL EQ 50MG BASE TABLET / ORAL AB RLD 2005-10-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020639-001 SEROQUEL EQ 25MG BASE TABLET / ORAL AB RLD, RS 1997-09-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020639-002 SEROQUEL EQ 100MG BASE TABLET / ORAL AB RLD 1997-09-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020639-003 SEROQUEL EQ 200MG BASE TABLET / ORAL AB RLD 1997-09-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020639-004 SEROQUEL EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-12-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020639-005 SEROQUEL EQ 300MG BASE TABLET / ORAL AB RLD, RS 2000-07-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020639-006 SEROQUEL EQ 400MG BASE TABLET / ORAL AB RLD 2005-10-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020639-007 SEROQUEL EQ 50MG BASE TABLET / ORAL AB RLD 2005-10-04 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020639-001 SEROQUEL EQ 25MG BASE TABLET / ORAL AB RLD, RS 1997-09-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020639-002 SEROQUEL EQ 100MG BASE TABLET / ORAL AB RLD 1997-09-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020639-003 SEROQUEL EQ 200MG BASE TABLET / ORAL AB RLD 1997-09-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020639-004 SEROQUEL EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-12-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020639-005 SEROQUEL EQ 300MG BASE TABLET / ORAL AB RLD, RS 2000-07-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020639-006 SEROQUEL EQ 400MG BASE TABLET / ORAL AB RLD 2005-10-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020639-007 SEROQUEL EQ 50MG BASE TABLET / ORAL AB RLD 2005-10-04 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020639-001 SEROQUEL EQ 25MG BASE TABLET / ORAL AB RLD, RS 1997-09-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020639-002 SEROQUEL EQ 100MG BASE TABLET / ORAL AB RLD 1997-09-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020639-003 SEROQUEL EQ 200MG BASE TABLET / ORAL AB RLD 1997-09-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020639-004 SEROQUEL EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** TABLET / ORAL RLD 1998-12-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020639-005 SEROQUEL EQ 300MG BASE TABLET / ORAL AB RLD, RS 2000-07-26 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 246 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67046-664-30 SEROQUEL 30 in 1 BLISTER PACK TABLET, FILM COATED 30 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded QUETIAPINE FUMARATE ACTIVE INGREDIENT 2S3PL1B6UJ SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 QUETIAPINE ACTIVE MOIETY BGL0JSY5SI SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 DIBASIC CALCIUM PHOSPHATE DIHYDRATE INACTIVE INGREDIENT O7TSZ97GEP SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 HYPROMELLOSE INACTIVE INGREDIENT 3NXW29V3WO SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 POLYETHYLENE GLYCOL INACTIVE INGREDIENT 3WJQ0SDW1A SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 POVIDONE INACTIVE INGREDIENT FZ989GH94E SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 WATER INACTIVE INGREDIENT 059QF0KO0R SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67046-664 SEROQUEL (QUETIAPINE FUMARATE) TABLET, FILM COATED [CONTRACT PHARMACY SERVICES-PA] 1 Legacy NDC, 1 package rows 20100616_276e53bf-d3c0-4457-a76e-ee39c1cd2a3d.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 67046-664-30 67046066430 30 in 1 BLISTER PACK Historical